
Sign up to save your podcasts
Or
Jorge Goldstein entered the fields of science and law at a time of immense change for them both. In the 1970s, huge strides were being made in biogenetics and microbiology, and in the 1980s, the intellectual property community was being asked to answer some giant questions they raised, like: How can you describe life, legally? Can a living being be patented? Who owns the material from your body?
The 45 years since the groundbreaking 1980 case of Diamond v. Chakrabarty, in which the U.S. Supreme Court decided that living organisms could be patented, have been an intensely busy time for microbiologists, biochemists, genetic researchers, and the patent lawyers who serve them. Goldstein, who holds a PhD in chemistry from Harvard University and a JD from George Washington University Law School, has been on hand to witness and help shape many of the resulting debates.
In Patenting Life: Tales from the Front Lines of Intellectual Property and the New Biology, Goldstein weaves stories from his own life and practice with the fascinating histories behind some well known medications, lesser known scientists, and groundbreaking court cases that will shape future scientific ventures. In this episode of the Modern Law Library, he and the ABA Journal’s Lee Rawles discuss the book and the fascinating career he’s had.
In the book, Goldstein explains many of the scientific developments behind technologies like CRISPR in a way that lay people can understand, while offering humanizing looks at the quirky and sometimes flawed scientists who made those discoveries. Large moral and ethical questions are raised about how technologies are developed, commercialized and put into practice, and he does not shy away from the discussions. He also offers his perspective on how patent law can be improved to fund further scientific advancements while also protecting innovation.
Goldstein and Rawles discuss key cases that helped shape genetic research, and some of the major changes he’s seen in legal theory over his career. They also discuss tikkun olam, a concept in Judaism about how our actions can repair and improve the world. It’s something Goldstein feels is a proper focus for science and for law, and they discuss two of the pro bono projects he has worked on with indigenous communities in which he can use patent law to protect their rights.
Finally, Goldstein offers advice to young scientists and attorneys who are interested in practicing in these fields, and shares his opinion on what artificial intelligence could mean in the patent law sphere.
4.8
3737 ratings
Jorge Goldstein entered the fields of science and law at a time of immense change for them both. In the 1970s, huge strides were being made in biogenetics and microbiology, and in the 1980s, the intellectual property community was being asked to answer some giant questions they raised, like: How can you describe life, legally? Can a living being be patented? Who owns the material from your body?
The 45 years since the groundbreaking 1980 case of Diamond v. Chakrabarty, in which the U.S. Supreme Court decided that living organisms could be patented, have been an intensely busy time for microbiologists, biochemists, genetic researchers, and the patent lawyers who serve them. Goldstein, who holds a PhD in chemistry from Harvard University and a JD from George Washington University Law School, has been on hand to witness and help shape many of the resulting debates.
In Patenting Life: Tales from the Front Lines of Intellectual Property and the New Biology, Goldstein weaves stories from his own life and practice with the fascinating histories behind some well known medications, lesser known scientists, and groundbreaking court cases that will shape future scientific ventures. In this episode of the Modern Law Library, he and the ABA Journal’s Lee Rawles discuss the book and the fascinating career he’s had.
In the book, Goldstein explains many of the scientific developments behind technologies like CRISPR in a way that lay people can understand, while offering humanizing looks at the quirky and sometimes flawed scientists who made those discoveries. Large moral and ethical questions are raised about how technologies are developed, commercialized and put into practice, and he does not shy away from the discussions. He also offers his perspective on how patent law can be improved to fund further scientific advancements while also protecting innovation.
Goldstein and Rawles discuss key cases that helped shape genetic research, and some of the major changes he’s seen in legal theory over his career. They also discuss tikkun olam, a concept in Judaism about how our actions can repair and improve the world. It’s something Goldstein feels is a proper focus for science and for law, and they discuss two of the pro bono projects he has worked on with indigenous communities in which he can use patent law to protect their rights.
Finally, Goldstein offers advice to young scientists and attorneys who are interested in practicing in these fields, and shares his opinion on what artificial intelligence could mean in the patent law sphere.
3,860 Listeners
38,559 Listeners
90,900 Listeners
20 Listeners
14 Listeners
10 Listeners
59 Listeners
26 Listeners
31 Listeners
22 Listeners
115 Listeners
6,277 Listeners
3,444 Listeners
1,943 Listeners
8 Listeners
45 Listeners
441 Listeners
43,270 Listeners
6,572 Listeners
9 Listeners
31 Listeners
151 Listeners
111,539 Listeners
32,481 Listeners
13 Listeners
47 Listeners
5,486 Listeners
15,222 Listeners
33 Listeners
39 Listeners
45 Listeners
4 Listeners
1,396 Listeners